APA (7th ed.) Citation

Putri, A., Rinaldi, I., Louisa, M., & Koesnoe, S. (2020). The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. Interna Publishing.

Chicago Style (17th ed.) Citation

Putri, Anastasia, Ikhwan Rinaldi, Melva Louisa, and Soekamto Koesnoe. The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. Interna Publishing, 2020.

MLA (9th ed.) Citation

Putri, Anastasia, et al. The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. Interna Publishing, 2020.